These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 2770506

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Properties of dermonecrotic toxin prepared from sonic extracts Bordetella bronchiseptica.
    Kume K, Nakai T, Samejima Y, Sugimoto C.
    Infect Immun; 1986 May; 52(2):370-7. PubMed ID: 3699886
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Purification of dermonecrotic toxin from a sonic extract of Pasteurella multocida SP-72 serotype D.
    Nakai T, Sawata A, Tsuji M, Samejima Y, Kume K.
    Infect Immun; 1984 Nov; 46(2):429-34. PubMed ID: 6542070
    [Abstract] [Full Text] [Related]

  • 8. Purification and characterization of Clostridium perfringens beta toxin.
    Sakurai J, Fujii Y.
    Toxicon; 1987 Nov; 25(12):1301-10. PubMed ID: 2449745
    [Abstract] [Full Text] [Related]

  • 9. Purification and characterization of the heat-labile toxin of Bordetella pertussis.
    Zhang YL, Sekura RD.
    Infect Immun; 1991 Oct; 59(10):3754-9. PubMed ID: 1894374
    [Abstract] [Full Text] [Related]

  • 10. [Isolation and certain properties of the dermonecrotic toxin from Pasteurella multocida].
    Kalmykova LI, Ezepchuk IuV, Shegidevich EA, Navasardiants DG.
    Mol Gen Mikrobiol Virusol; 1991 Aug; (8):29-32. PubMed ID: 1784303
    [Abstract] [Full Text] [Related]

  • 11. Purification of three fragments of the dermonecrotic toxin from Pasteurella multocida.
    Nakai T, Kume K.
    Res Vet Sci; 1987 Mar; 42(2):232-7. PubMed ID: 3108979
    [Abstract] [Full Text] [Related]

  • 12. Purification and characterization of alpha-toxin of Clostridium oedematiens type A.
    Izumi N, Kondo H, Ohishi I, Sakaguchi G.
    Jpn J Med Sci Biol; 1983 Jun; 36(3):135-46. PubMed ID: 6632349
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Theta-toxin of Clostridium perfringens. I. Purification and some properties.
    Yamakawa Y, Ito A, Sato H.
    Biochim Biophys Acta; 1977 Oct 26; 494(2):301-13. PubMed ID: 199270
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the dermonecrotic toxin in members of the genus Bordetella.
    Walker KE, Weiss AA.
    Infect Immun; 1994 Sep 26; 62(9):3817-28. PubMed ID: 8063398
    [Abstract] [Full Text] [Related]

  • 18. Purification and some properties of cytotoxin produced by Clostridium difficile.
    Katoh T, Honda T, Miwatani T.
    Microbiol Immunol; 1988 Sep 26; 32(6):551-64. PubMed ID: 3173147
    [Abstract] [Full Text] [Related]

  • 19. Purification and characterization of Clostridium perfringens iota toxin: dependence on two nonlinked proteins for biological activity.
    Stiles BG, Wilkins TD.
    Infect Immun; 1986 Dec 26; 54(3):683-8. PubMed ID: 2877949
    [Abstract] [Full Text] [Related]

  • 20. Molecular aspects of Bordetella pertussis pathogenesis.
    Locht C.
    Int Microbiol; 1999 Sep 26; 2(3):137-44. PubMed ID: 10943406
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.